Company / PP&E per Share
Intellia Therapeutics, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.17
FY2025
5-year range
$0.17 / $0.38
FY2021-FY2025
Trend
-41.2%
vs FY2024
Sector context
#117 of 133
Health Care
What the data says
Intellia Therapeutics, Inc.'s pp&e per share of $0.17 is lower than 88% of companies in the Health Care sector (FY2025). Declined from $0.38 to $0.17 over the past 2 years.
Based on SEC 10-K filings.
0.17 in FY2025 with a 5-year CAGR of -11.4%.
Declined from $0.38 to $0.17 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -22.7%
- 5-Year CAGR
- -11.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 133This company $0.17 Sector average $11.65
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 41.2% year-over-year.
- Ranks #117 out of 133 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.17 | -41.2% |
| FY2024 | $0.29 | -21.7% |
| FY2023 | $0.38 | +0.3% |
| FY2022 | $0.37 | +18.4% |
| FY2021 | $0.32 | -0.3% |
| FY2020 | $0.32 | -20.2% |
| FY2019 | $0.40 | -1.1% |
| FY2018 | $0.40 | -5.1% |
| FY2017 | $0.42 | -11.3% |
| FY2016 | $0.48 | -95.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026